Alzheimer's disease

A once fringe theory that viral and bacterial infections trigger the neuroinflammation and cognitive decline associated with Alzheimer’s disease is gaining traction. If it proves true, available antimicrobials could be a long sought-after treatment for this neurodegenerative disease.

Scientists leverage the natural ability of antibodies to cross the blood-brain barrier and target proteins implicated in neurodegenerative disease.

LIVE August 26th, 2021 at 11:00 AM ET

In this webinar, experts will discuss new approaches to identify small therapeutic candidates targeting diabetes and Alzheimer’s disease.

Spending an hour every day listening to a low-pitched thrum and gazing at blinking lights may help prevent structural changes in the brain and cognitive impairments associated with Alzheimer’s disease.

LIVE June 17th, 2021 at 2:30 PM ET
This webinar will discuss recent disease and drug discoveries enabled through screening CRISPR-modified stem cells.

University of Arizona researcher looks beyond traditional causes to find novel therapies

Lilly’s donanemab Phase 2 trial brings positive results

Four compounds show promise against Alzheimer’s

Natural compound attacks Alzheimer’s disease early